title: Effect of opioid dependence pharmacotherapies on zidovudine disposition.
abstract: Injection drug users are frequently infected with human immunodeficiency virus (HIV) and receive opioid dependence pharmacotherapies and zidovudine (ZDV), the latter as a component of highly active antiretroviral therapy. We previously reported that methadone substantially increases ZDV concentrations. We now report on oral ZDV pharmacokinetics in 52 subjects receiving the opioid dependence pharmacotherapies l-alpha-acetylmethadol LAAM, buprenorphine, or naltrexone, and 17 non-opioid-treated controls. Relative to the area under the time-concentration curve (AUC) of ZDV in control subjects, no statistically significant differences in ZDV AUC were observed in participants treated with LAAM (p = .75), buprenorphine (p = .37), or naltrexone (p = .34). While methadone maintenance may result in ZDV toxicity and possibly require dose adjustments, other opioid pharmacotherapies should not produce ZDV toxicity.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY 10461, USA. emccance@montefiore.org
authors.forename: E F
authors.initials: EF
authors.lastname: McCance-Katz
authors.forename: P M
authors.initials: PM
authors.lastname: Rainey
authors.forename: G
authors.initials: G
authors.lastname: Friedland
authors.forename: T R
authors.initials: TR
authors.lastname: Kosten
authors.forename: P
authors.initials: P
authors.lastname: Jatlow
mesh_terms: D019380:Anti-HIV Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002047:Buprenorphine / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008692:Methadyl Acetate / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D011863:Radioimmunoassay; D015813:Substance Abuse Detection; D013997:Time Factors; D015215:Zidovudine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D009292:Narcotic Antagonists; D009294:Narcotics; D002047:Buprenorphine; D015215:Zidovudine; D009271:Naltrexone; D008692:Methadyl Acetate